Protocol AI featured in The Lancet Group Journal

Clinical trial design and protocol development is a scientific task involving multiple scientists and disciplines. Any solution supporting this work must therefore follow a rigorous scientific approach and undergo proper validation, commercial claims alone are not enough for such a highly sensitive and critical task.

From day one, scientific validation of every model and feature we develop has been our highest priority. 13 peer-reviewed publications confirm this approach.

Thank you to the authors Bilal A Mateen, Vasee Moorthy MD PhD, Alain Labrique and Jeremy Farrar for recognizing the real-world impact of reducing time and effort in protocol development, and for featuring Protocol AI as an example of a solution that can deliver meaningful results.

You can read the full paper here: https://lnkd.in/ei-RjJme